Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone

Greiner, M. G., Shulman, M., Scodes, J., Choo, T.-H., Pavlicova, M., Opara, O., Campbell, A. N. C., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2022). Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone. Substance Use & Misuse, 57(11), 1732–1742. https://doi.org/10.1080/10826084.2022.2112230
Authors:
Miranda G Greiner
Matisyahu Shulman
Jennifer Scodes
Tse-Hwei Choo
Martina Pavlicova
Onumara Opara
Aimee N C Campbell
Patricia Novo
Marc Fishman
Joshua D Lee
John Rotrosen
Edward V Nunes
Affiliated Authors:
Miranda G Greiner
Matisyahu Shulman
Jennifer Scodes
Tse-Hwei Choo
Martina Pavlicova
Onumara Opara
Aimee N C Campbell
Edward V Nunes
Subjects:
Author Keywords:
opioid abstinence
buprenorphine
extended-release injectable naltrexone
opioid use disorder
Publication Type:
Article
Unique ID:
10.1080/10826084.2022.2112230
PMID:
Publication Date:
Data Source:
PubMed

Record Created: